Have you looked at the Billing Utilisation figure? They will still keep growing revenue.
But as stated previously, the answer is the operating leverage.
If we had the same increase in revenue for the next 6 month period. The percentage of revnue growth will fall to a lower figure but NPAT will continue to ramp up at a very healthy rate.
- Forums
- ASX - By Stock
- NXT
- Ann: Half Yearly Report and Accounts
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

Ann: Half Yearly Report and Accounts, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14695 | 14.190 |
4 | 10094 | 14.180 |
1 | 2695 | 14.170 |
4 | 9059 | 14.160 |
1 | 2969 | 14.150 |
Price($) | Vol. | No. |
---|---|---|
14.280 | 100 | 1 |
14.290 | 5808 | 1 |
14.310 | 7418 | 5 |
14.330 | 5808 | 1 |
14.350 | 5808 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online